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Delirium is a neuropsychiatric syndrome characterized by altered consciousness and attention with cognitive, emotional and
behavioural symptoms. It is particularly frequent in elderly people with medical or surgical conditions and is associated with
adverse outcomes. Predisposing factors render the subject more vulnerable to a congregation of precipitating factors which
potentially affect brain function and induce an imbalance in all the major neurotransmitter systems. Early diagnosis of delirium
is crucial to improve the prognosis of patients requiring the identification of subtle and fluctuating signs. Increased awareness
of clinical staff, particularly nurses, and routine screening of cognitive function with standardized instruments, can be decisive
to increase detection rates of delirium. General measures to prevent delirium include the implementation of protocols to
systematically identify and minimize all risk factors present in a particular clinical setting. As soon as delirium is recognized,
prompt removal of precipitating factors is warranted together with environmental changes and early mobilization of patients. Low
doses of haloperidol or olanzapine can be used for brief periods, for the behavioural control of delirium. All of these measures are
a part of the multicomponent strategy for prevention and treatment of delirium, in which the nursing care plays a vital role.
1. Introduction
Delirium is a neuropsychiatric syndrome of acute onset and
fluctuating course, clinically characterised by altered level
of consciousness, attention, and disturbance in orientation,
memory, thought, and behaviour. The term delirium literally
means, “out of the track”, and was firstly used by Celsus, in
the first century A.D. to describe either states of agitation
or excessive somnolence [1]. Historically, this syndrome has
been described under different names and classifications [2].
Gradually the term delirium started to be more consistently
used to designate reversible states of acute brain dysfunction,
associated with fever or medical and/or surgical conditions.
Delirium is a common occurrence in medical or sur-
gical wards and affects particularly elderly people with co-
morbidities and prior cognitive impairment. Thus, this syn-
drome affects 11–42% of medically ill patients [3] and
complicates 24–89% of hospitalizations for elderly patients
with dementia [4]. The prevalent rates in the community
are somewhat lower, ranging from 0.5% [5] to 13% for
older adults with dementia [6]. In elective orthopaedic
surgery, the incidence of postsurgical delirium is between 9–
28% [7, 8]. Higher rates are seen in emergent hip fracture
surgery, in which a large proportion of patients present with
preoperative (4%–36%) or postoperative delirium (up to
53%) [9]. Postoperative delirium after cardiac surgery varies
from 2 to 57%, according to the procedure, type of patients
and methodology of the study [10–13]. In the context of
sepsis, delirium affects, 9% to 71% of patients [14].
Delirium is independently associated with adverse out-
comes consisting not only of increased hospital stay, mor-
bidity and mortality, but also long-term effects such as
cognitive and functional deterioration and higher rates of
institutionalization [15–19]. Delirium, therefore, imposes a
significant economic burden on health care systems, standing
side by side with diabetes mellitus and falls as a major cause
of increasing costs being directly responsible for an addi-
tional cost of more than $60,000 patient/year [20]. Despite
2 Nursing Research and Practice
its importance, health care professionals often fail to recog-
nise the syndrome, and acute medical care has been found
insufficient to meet the complex care needs of these frail
older adult. Also, more specialised clinical services, for ex-
ample, acute care for the elderly, have been associated with
a decreased incidence of delirium [21], suggesting that the
multidisciplinary approaches may be more beneficial in both
detecting and treating delirium.
The clinical relevance of delirium has led to the develop-
ment of best practice guidelines by the American Psychiatric
Association, [22, 23] British Geriatrics Society (BGS) [24],
and, more recently, by the National Institute of Clinical
Excellency (NICE) [25] which is a particularly exhaustive
and cutting-edge document. Since the publication of the
NICE guidelines, a number of additional pharmacological
prophylaxis and treatment studies have followed and have
contributed to further development of our understanding of
best practice for delirium.
Nurses are in a particularly relevant position in the
healthcare system to improve detection rates, manage and
provide necessary care to people with delirium, and prevent
these episodes in those at high risk [26]. In the current paper,
we reflect on the clinical recognition and early diagnosis of
delirium, as well as the available evidence addressing the
most effective measures for prevention and treatment.
2. Clinical Definition and Psychopathological
Features of Delirium
Health care staff, including nurses, should be aware that
different terms used in scientific literature and in clinical
practice (e.g., acute confusional state, encephalopathy, acute
brain failure, organic brain syndrome) all refer to conditions
that would meet the definition criteria of delirium. At
present, delirium is included in the two main classification
systems: the revised fourth edition of the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV-TR) [27]
and the International Classification of Diseases (ICD-10)
[28].
DSM-IV-TR Diagnostic Criteria. In DMS-IV-TR delirium
is defined by the presence of disturbed consciousness (i.e.,
reduced clarity of awareness of the environment with re-
duced ability to focus, to sustain, or to shift attention) and a
change in cognition (such as memory deficit, disorientation,
or language disturbance) or the development of a perceptual
disturbance that is not better accounted for by a preexisting,
established, or evolving dementia. The disturbance develops
over a short period of time (usually hours to days) and
tends to fluctuate during the course of the day. There should
be evidence from clinical history, physical examination,
and/or laboratory findings, that the disturbance is caused by
direct physiological consequences of either a general medical
condition, substance intoxication/withdrawal, or multiple
etiologies [27].
ICD-10 Diagnostic Criteria. The diagnostic criteria for delir-
ium provided by the ICD-10 require the presence of five
clinical features of the syndrome: impaired consciousness
and attention, global disturbance of cognition as well as
psychomotor, sleep and emotional disturbances [28]. This
can probably explain why ICD-10 has relatively lower
sensitivity than DSM-IV [29].
2.1. Core Symptoms of Delirium. The fundamental psycho-
pathological features of delirium are disturbed consciousness
(level of awareness or the ability to stay awake) and reduced
levels of attention (capacity to recruit and maintain senses
focused on relevant, stimuli) which directly impair the
capacity to monitor, select and integrate cognitive stimuli.
Inattention is the most frequent clinical finding in a
delirium episode. If severe enough, it can be detected during
a clinical interview (e.g., the patient is unable to follow
a conversation). In mild cases, impairment of attention is
elicited only by formal cognitive testing (e.g., digit span,
serial sevens, or naming the months in reverse order). At-
tention is impaired in early stages and throughout the
course of a delirium episode, correlating with the severity of
cognitive deficits [30, 31].
Consciousness refers to the state of being awake and able
to interact with the environment, allowing the integration
of stimuli within the cognitive experience. In this sense, dis-
turbed consciousness can be considered as an impairment in
alertness (wakefulness), awareness, and arousal [32]. When
present in a patient with an acute medical condition, the
likelihood of delirium is high [29].
The sudden and global impairment in cognition charac-
teristic of delirium is manifested as difficulty in
(i) orientation (impaired awareness of oneself and one’s
surroundings in terms of time, place and person);
(ii) memory (impaired ability to learn new information
or to recall previously learned information);
(iii) language and thought (disturbance in the compre-
hension and/or expression of speech as well as abnor-
malities in the flow and connectivity of thought);
(iv) visuospatial abilities (impaired capacity to construct
and draw geometric configurations).
Specific deficits in visual perception, not necessarily
related with cognitive performance, have been described in
people with delirium [33]. These may underlie perceptual
disturbances, particularly of visual modality, such as
(i) illusions (misinterpretations of real sensory stimuli,
as when the patient in a dark environment sees a
threatening figure emanating from shadows on the
walls) (see Figure 1),
(ii) hallucinations (ranging from simple flashes or un-
structured sounds to elaborate visions, that occur
without corresponding sensory stimuli).
2.2. Associated Symptoms of Delirium. A range of behav-
ioural and emotional symptoms, not specifically described
in DSM-IV criteria but more adequately reflected in ICD-10,
are frequently observed during delirium: sleep-wake distur-
bances, lability of affect, delusions, and motor disturbances.
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Figure 1: Relationship between predisposing, protective, and
precipitating factors in delirium.
Disturbances in sleep-wake cycle are common in patients with
delirium ranging from mild sleep continuity disturbance
at night or occasional drowsiness during the day to severe
circadian fragmentation with multiple periods of sleep and
wakefulness.
When present, delusional ideas consist of false beliefs
usually of suspicious or persecutory content (paranoid
ideation) poorly systematized and containing relatively few
elements (simple delusions). Patients often do not spon-
taneously verbalize these ideas as they are frightened and
quite guarded. Instead, they are more likely to manifest a
range of emotions associated with a sense of threat (appre-
hension, worry, irritability, or “distress” as stated in NICE
guidelines [25]). Not surprisingly, lability of affect (or mood)
is frequently observed in subjects with delirium and this
is characterized by rapid emotional shifts, often within
seconds to minutes. Contrary to common belief, there is
evidence that most patients will retain in the future, vivid
and detailed memories about experiencing delirium. Acute
confusion is remembered as a state dominated by mixed
emotions associated with recent and distant memories of
events, places, and people with dissolution of time and space
which are organized in a dream-like narrative. Although
this can sometimes be difficult to express in words, for
most patients delirium is a negative experience, inducing
discomfort even after recovery, originated by worries about
what had happened to them [34].
Changes in motor behaviour have been recognized for
long in patients with delirium involving either overactivity
(e.g., restlessness or agitation) or underactivity (motor retar-
dation). Aggressive behaviour may occur as a consequence of
increasing levels of paranoid ideation and irritability, poten-
tiated by other factors (e.g., hunger, sleepiness, and pain).
Trying to reassure the patient often increases suspiciousness
as the interviewer may be perceived as being involved in the
plot. Thus, it is usually more helpful to acknowledge the
patient’s concerns and to follow a patient-centred interview
in order to trace his beliefs.
Overall, there is a lack of evidence about the different
patterns of motor activity and their stability during a
delirium episode. Particularly, there is a lack of agreement
about whether motor features should be independently
assessed or clustered with the associated neurobehavioural
symptoms [35].
2.3. Delirium Subtypes. In clinical practice, it is common
to classify delirium into different subtypes, based on the
predominance of these “psychomotor features”. Thus, the
hypoactive subtype is characterized by reduced alertness,
sedation, and reduction of motor activity, whereas, the
hyperactive form is associated with hypervigilance, overt
psychotic features (e.g., hallucinations, delusions), and agita-
tion. Please note that psychotic features are also present albeit
less frequently in people with hypoactive delirium (reviewed
by Friedlander et al. 2004 [36]). As it became apparent that
most cases of delirium have overlapping features of these
two subtypes, a third, mixed, subtype was proposed [37].
However, in recent years, it has been noted that a small
portion of delirium patients (3–22%) do not have evidence
of a motor component in their clinical symptomatology over
the previous 24 hours, and thus do not meet the criteria for
hypo-, hyper-, or mixed form of delirium [29, 38, 39]. In this
context, a new subtyping scheme proposed by Meagher et al.,
designed for use by medical and nonmedical professionals,
can be a useful tool to characterize the motor features of
delirium [39].
Interestingly, the hyperactive subtype is still considered
as the predominant form of delirium (up to 80% of medical
students, Mukaetova-Ladinska, unpublished data), despite
the lower prevalence rates. In fact, the mixed and hypoactive
subtypes are more prevalent (55% and 46%, resp., [40, 41]).
In particular, the hypoactive delirium type is associated with
higher mortality [42], older age (22% in adults versus 41%
in elderly [40]), palliative care needs [43], polycomorbidity
[44], and severity of illness [45] and is usually either
overlooked and undiagnosed (in particular in intensive care
setting [41]) or misdiagnosed as depression or fatigue [43].
Thus the current prevalence rates for the hypoactive delirium
may be largely underestimated.
3. Pathophysiology of Delirium
Delirium is the clinical manifestation of an acute and global
disruption in brain homeostasis, resulting in the failure of
high integrative cognitive, behavioural, and emotional func-
tions (discussed above). Thus, any kind of insult affecting the
neurophysiological processes of the central nervous system
(CNS) can elicit an episode of delirium.
3.1. The Multifactorial Nature of Delirium. In the light of a
diversity of medical or surgical conditions associated with
delirium, it remains largely unknown how pathophysiolog-
ical changes occurring in the periphery can result in the
disruption of brain function. Yet, it is clear that some factors
(e.g., increased age, dementia, high burden of comorbidities)
render the subject more prone to develop delirium when
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exposed to even minor insults (e.g., urinary tract infection).
Also, numerous studies in different clinical settings have
shown that delirium is a heterogeneous condition and can
be elicited by the combined action of a diversity of factors
(Table 1). Thus, the pathophysiology of delirium is currently
conceptualized as being the complex and dynamic interplay
between predisposing, protecting, and precipitating factors
in a given patient. Most common precipitating factors of
delirium are medication, metabolic disorders, infection,
surgical procedures, and CNS disorders (Table 2).
3.2. Proposed Pathophysiological Pathways. Several studies
which have focused on identifying the neurochemical chan-
ges during delirium found an imbalance in all the main
neurotransmitters (acetylcholine, serotonin, dopamine, glu-
tamate, GABA). Also, neuropeptides, catecolamines, cortisol,
and inflammatory markers have been implicated in delirium
pathophysiology [48].
Currently, the two main theories for delirium patho-
physiology are cholinergic deficiency and aberrant stress
response/neuroinflammation.
Probably, the first evidence supporting the cholinergic
deficiency hypothesis originated from the observation that
delirium, cognitive impairment, and psychosis are induced
by toxics (Atropa belladonna) and drugs with anticholinergic
action (e.g., tricyclic antidepressants, antihistamines) [49].
In addition to direct pharmacological antagonism, failure of
cholinergic system during delirium has been proposed to be
also the result of disruption in acetylcholine (ACh) synthesis,
transport, and release [50]. Indeed, metabolism of ACh is
intimately related to energetic status of neurons as it of its
steps are dependent on adenosine triphosphate (ATP, the
major source of energy for most metabolic processes in living
organisms and cells) and its precursor Acetyl-Coenzyme A.
Any insult that affects the oxidative chain, such as hypoxia or
inflammation, can then impair ACh availability in the brain
and disrupt several cognitive processes. Acetylcholine deficit,
due to cholinergic neuronal loss, has been considered a
potential mechanism explaining the recognized susceptibility
of patients with dementia to develop delirium [51]. Thus,
despite being elicited by a wide number of causes, central
cholinergic deficit has been proposed as a “final pathway” to
delirium considering that its clinical presentation is relatively
stereotyped [52, 53].
More recently, animal experiments, particularly those
by Cunningham et al., have clearly shown that periph-
eral or local precipitating factors (e.g., lipopolysaccharide)
can evoke pathophysiological events within the Central
Nervous System (CNS), with production of proinflamma-
tory cytokines by microglial cells. These neuroinflamma-
tory changes are coupled with associated cognitive and
behavioural disturbances, the so-called “sickness behavioural
syndrome” similar to delirium [54, 55]. A related hypothesis
postulates that an aberrant stress response with exaggerated
production of cortisol underlies the pathophysiological
features of delirium [56]. In line with this evidence, several
studies in medical and surgical patients have shown that
plasma levels of several inflammatory markers, particularly
IL-6, and cortisol are altered before and/or during delirium
supporting the aberrant stress response/neuroinflammatory
hypothesis of delirium. Interestingly, a significant interaction
exists between the cholinergic system and the innate immune
response through the “cholinergic anti-inflammatory path-
way” [57]. Although not presently available, pharmacolog-
ical strategies that can modulate the aberrant stress re-
sponse/neuroinflammatory pathway may well offer new
therapeutic tools to be used in the management of delirium.
Neurochemical and Neuroimaging Changes in Delirium.
Functional neuroimaging studies report significant although
nonspecific reductions in brain blood perfusion [58] and
white matter hyperintensities [59] during delirium. Sim-
ilarly, lower fractional anisotropy values (determined by
diffusion tensor imaging) of deep white matter and thalamus
have been identified in elderly with postoperative delirium
[60]. However, since many of the delirious patients in these
studies had impairments in memory, executive function,
and attention at three months, in absence of baseline
cognitive impairment [59], further studies are now needed
to examine the relationship between currently available
imaging techniques and their usefulness in diagnosing and
further characterisation of the delirium syndrome. Since
dementia with Lewy bodies and delirium share somewhat
similar clinical phenotype [61], it would be of interest to see
whether the currently available DaTSCAN (Ioflupane, 123-
I FP-CIT) may find a role in the differential diagnosis of
delirium.
4. Delirium Diagnosis
Considering that delirium has no pathognomonic features,
central to the diagnosis is the identification of a cluster of
nonspecific signs and symptoms (described above) within
a temporal frame that links the onset or exacerbation of
a general medical condition (and/or substance use) to the
change in mental status. Thus, there is an overall agree-
ment that delirium is far more frequent than it is recognized
by medical or nursing staff. Importantly, under or mis-
recognition of delirium is associated with adverse outcomes,
including increased mortality [62]. The first step to address
this problem is to increase the awareness of all healthcare
providers, even nonspecialists, about the clinical relevance of
delirium in clinical setting [25].
4.1. Recognizing the Warning Signs of Delirium. A high de-
gree of clinical expertise is crucial to detect any acute change
in patient’s mental status presenting as the early signs of
delirium. Recognition of hypoactive delirium is particularly
challenging and demands a careful monitoring of patient’s
behaviour at the bedside in order to detect worsened con-
centration, reduced mobility or motor activity, changes in
appetite or social withdrawal.
The presence of factors associated with increased risk of
delirium (age ≥ 65, prior or present cognitive impairment,
current hip fracture, and severe illness) warrants a more
close clinical monitoring. Irrespective of that, all patients
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Table 1: Risk factors for delirium [10, 46, 47].
(A) Medical setting
Visual impairment Severe illness
Cognitive impairment Dehydration
(B) Postoperative delirium (cardiac surgery)
Cerebrovascular disease Diabetes mellitus
Peripheral vascular disease Preoperative atrial fibrillation
Impaired left ventricular ejection fraction Preoperative cardiogenic shock
Urgent operation Intraoperative haemofiltration
Prolonged duration of surgery High blood transfusion requirement
(C) Postoperative delirium (non-cardiac surgery)
Cognitive impairment Older age
Functional impairment Sensory impairment
Depression Preoperative psychotropic drug use
Psychopathological symptoms Medical comorbidity
Table 2: Conditions commonly associated with delirium.
Primary CNS disorders
Traumatic brain injury Abscess
Stroke Subdural haematoma
Tumours Encephalitis
Seizures
Systemic disorders
Inflammatory/infectious
Sepsis Pneumonia
Trauma Urinary tract infection
Organ dysfunction
Electrolyte abnormalities Hypoglycaemia, Hyperglycaemia
Renal failure Hepatic failure
Neoplasm Burns
Cardiac insufficiency Respiratory insufficiency
Anaemia Pain
Substance-induced
Medications
Anticholinergic Antibiotics
Opioids Anaesthetics
Sedative-hypnotics Antineoplastics
Corticosteroids Antihypertensives
Drugs of abuse Toxics
admitted to the hospital should be regularly assessed for de-
lirium (at least daily) [25]. Some authors recommend daily
chart reviews of patient status based on nursing and medical
notes as a complementary method to detect delirium. Al-
though this can be a source of misidentification of delirium
(especially when the patient has dementia, severe illness
or high baseline delirium risk [63]), chart-based detection
associated with standard assessment has proved to be useful
in some particular settings, such as in Intensive Care Units
[64].
Use of predictive models can also be a cost-effective
method of selecting patients with high-risk of delirium, in
whom screening should be done as a routine practice. The
distinction between the longstanding cognitive impairment
and the acute onset confusion relays on a good collateral
information from relatives and carers. A simple question
directed to a patient’s friend or relative (“Do you feel that
[patient’s name] has been more confused lately?”) has shown
to have a sensitivity of 80%, a specificity of 71%, and a high
negative predictive value (91%) in relation to the diagnosis
of delirium based on a psychiatric interview [65]. When
assessing patients with delirium, it is necessary to use a more
focused and structured interview when compared to other
patients. This can be achieved by using simple, closed-ended
questions, redirecting the patient and do not allow long
periods of silence.
4.2. Confirmation of Diagnosis. A healthcare professional
proficient in the diagnosis of delirium should carry out
the assessment of patients presenting with warning signs.
Although DMS-IV or ICD-10 criteria remain the gold-
standard for diagnosis of delirium, Confusion Assessment
Method (CAM) and CAM-ICU (for critically ill patients) are
valid alternatives [25].
The CAM is a simple instrument initially developed
for screening of delirium by trained nonpsychiatrists. The
diagnostic algorithm, based on DSM-III-R criteria, assesses
four features: (1) acute onset and fluctuating course (2)
inattention (3) disorganized thinking (4) altered level of
consciousness. Delirium is diagnosed when both acute
onset/fluctuating course and inattention are present (features
1 and 2) and at least one of other two features. CAM was
first validated in a sample of 56 medical patients and found
to have high sensitivity (94 to 100%) specificity (90–95%)
and inter-rater reliability when compared to psychiatric
comprehensive assessment [66]. It is easy to administer and
can be completed in 5–10 minutes based on observations
made during an interview that should include some formal
cognitive assessment (e.g., Mini-Mental State Examination).
In hospital setting, the CAM test has a sensitivity ranging
from 43% to 90% and a specificity from 84% to 100% (when
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using DSM-IV criteria as the reference) [67]. The CAM-ICU
assess on the presence or absence of the following features:
acute onset or fluctuation course and inattention and either
disorganized thinking or altered level of consciousness, and
has a sensitivity to detect delirium of 93–100%, and speci-
ficity of 98–100%, and similarly, high inter-rater reliability
[68]. When the CAM is rated by untrained nurses and
without any formal cognitive assessment, delirium is often
unrecognized [69]. Thus, although CAM is currently the
most widely used instrument for detection of delirium,
adequate training is necessary to enhance its sensitivity
and specificity. Furthermore, this training should involve
nursing staff engaged in the care of people with delirium, to
improve their clinical skills in detecting and monitoring these
patients.
4.3. Additional Assessment. Apart from CAM, a large number
of other instruments have been developed to improve de-
tection rates of delirium and/or to measure its severity
(reviewed in Adamis et al. [70]). Among those, some have
been adequately validated.
(i) Delirium Rating Scale (DRS) was designed to mea-
sure the severity of delirium [71]. A substantially
revised version of DRS was published in 1998 (DRS-
R-98), consisting of a 3-item diagnostic section and
13-item severity section to be scored in the first
assessment. For longitudinal assessments only, the
severity items should be rated from 0 to 3 points
based on all sources of information available [72].
(ii) Memorial Delirium Assessment Scale (MDAS) has
been widely used in critical care and in patients
with advanced cancer. It consists of a 10-item scale
assessing for cognition (3 items) and neuropsychi-
atric symptoms and is best suited for quantification
of delirium severity rather than for screening or
diagnosis [73].
(iii) The Neelon and Champagne (NEECHAM) Con-
fusion Scale was developed by nurses in order to
assess patients based on observations in the course
of providing care to patients. It contains nine
items divided into three subscales (responsiveness-
information processing, behavior, and vital func-
tions). [74] A score of 30 indicates normal function
and 0 severe confusion with a cutoff point for
delirium of 24.
(iv) Delirium Observation Screening Scale (DOS) was
developed to rate nurses’ observations during regular
care [75]. The scale has a good predictive validity
against the diagnosis made by a geriatrician based
on DSM-IV criteria and has a concurrent validity, as
tested by comparison with CAM, of 0.63.
Nonspecific tests for delirium (e.g., MMSE [76], Clock
drawing test [77]) can also be useful for establishing
the baseline cognitive level of the patients, which can be
compared with the subsequent assessments. However, they
are not recommended as screening or diagnostic tools for
delirium [25].
4.4. Differential Diagnosis with Dementia. DSM-IV-TR un-
derscores the importance of considering a pre-existing,
established or evolving dementia that can better explain
the symptoms of delirium. Yet, there is a close association
between the two conditions. Thus, delirium complicates 24
to 89% of inpatient stays for elderly patients with dementia
[4]. Inversely, the available evidence strongly suggests that
delirium increases the risk of new-onset dementia at long
term, as much as 6-fold at three-year followup [17]. Also,
people with pre-existing dementia suffer from an accelera-
tion of cognitive decline following an episode of delirium
[78].
Delirium is said to be superimposed on a dementia when
an acute change in mental status occurs in a subject with
an ongoing dementia. Failure to differentiate delirium from
pre-existing dementia is clinically relevant as it can lead
to serious medical conditions being missed and thus not
treated. This may be particularly true when behavioural or
cognitive changes in a patient with dementia are attributed
to “normal” fluctuation of symptoms of the underlying
dementia than to superimposed delirium [79].
While both delirium and dementia are characterized by
a global impairment of cognition, they can be differentiated
based on clinical features and natural course (Table 3). Thus,
in delirium the global cognitive impairment emerges rapidly
in a patient with disturbed consciousness and attention in
the context of a medical or surgical condition. This contrasts
with demented nondelirious subjects in whom cognitive
impairments are primarily caused by the sustained, progres-
sive brain disorder rather than by a dysfunction of con-
sciousness and attention which are generally preserved.
However, there is a substantial clinical overlap between the
two conditions and it may prove difficult to differentiate
between the 2 syndromes.
There is no strong evidence that delirium has distinct
features when occurring in people with prior dementia [80].
However, recent studies suggest that level of consciousness
and hyperactive motor features can be more frequent among
delirious demented patients than in nondemented patients
with delirium [81, 82]. The key issue in diagnosing delirium
in demented patients is to determine whether there is
a change in the baseline clinical picture or whether the
presenting symptoms are only an expression of pre-existing
cognitive disorder. For that, it is crucial to have knowledge
of the premorbid mental status, which can be achieved
by clinical evaluation and/or collateral information (family
caregivers, family practitioners, etc.). Clinical diagnosis of
delirium in patients with dementia should focus, therefore,
primarily on assessment of level of consciousness and at-
tention rather than global cognitive impairment, which are
common to both. Nevertheless, the crucial issue in the clini-
cal daily practice is not so much to classify a patient as having
pure forms of delirium or dementia but, rather to identify
and remove the reversible components of the clinical picture
[83]. Thus, in practical terms any confused patient should be
considered to have delirium until proven otherwise.
4.5. Factors Associated with Delirium Under Recognition. The
hypoactive form of delirium (representing the majority of
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Table 3: Differentiating Delirium from Dementia.
Features Delirium Dementia
Onset Clear-cut, acute (hours to days) Insidious (months to years)
Identifiable precipitant Yes No
Course Fluctuating (sun-downing effect) Stability of symptoms within days
Duration Reversible Resolution in days or weeks Not reversible Continuously progressive
Level of consciousness Impaired Usually not impaired (exception: DLB, VaD)
Level of attention Impaired Usually not impaired (exceptions: DLB, VaD, FTD)
Mood changes Frequent Rare (exceptions VaD)
Hallucinations, Illusions Frequent, predominantly visual Rare (exception: DLB)
Delusions Frequent (fluctuating, fragmented) Rare
Motor activity Hyperactive/Hypoactive/Mixed Without specific features
DLB: Dementia with Lewy Bodies
VaD: Vascular Dementia
FTD: Fronto-Temporal Dementia.
cases, as reviewed above) and delirium in individuals with
advanced age, sensorial deficits, prior cognitive impairment,
or dementia and medical problems like infection or dehy-
dration are the main reasons for the acute confusional sate
not being recognised and diagnosed [69, 84, 85]. Hypoactive
delirium and dementia comorbidity, appear to be the best
predictors for overlooking delirium in the elderly with cog-
nitive impairment [69]. Similarly, presence of dementia
influences the survival time and is associated with higher
death risk, irrespectively of the delirium subtype [86, 87].
This may be due to the higher rates of polycomorbidities
[44] and use of neuroleptic medication in dementia subjects,
already described to be associated with higher death risk [88].
All these findings indicate the need for further improvement
of the medical status and care, especially for the elderly
with dementia, in order to decrease the risk factors for a
delirium episode in this frail population. Additional causes
of underrecognition of delirium associated with healthcare
providers include misinterpreting compliant behaviour as an
indicator of intact cognition and normalization of behaviour
changes (e.g., “he’s only tired”, “it is normal to get confused
during an infection”).
5. General Assessment
A detailed medical history, preferably obtained from differ-
ent sources, should assess comorbidities and must include
a careful review of medication with particular attention to
recently introduced or discontinued drugs and those with
anticholinergic potential. Physical examination should eval-
uate major systems and vital signs searching for medical
causes of delirium. Pain and sensorial impairment should
also be assessed. Useful auxiliary exams generally include
blood count, electrolytes, renal, hepatic function, urine anal-
ysis, chest X-ray and ECG. Whenever considered necessary,
other assessments should be requested, for a complete
evaluation (e.g., toxicologic analysis, neuroimaging, lumbar
puncture) (Table 4). Frequently, patients with dementia
simultaneously have multiple subthreshold conditions whose
conjugation can precipitate delirium (e.g., pressure ulcers,
Table 4: General assessment of confused patient to identify and
treat possible causes.
Physical frailty Sensory impairment (deafness, visual)
Severe illness Surgery (e.g., fractured neck of femur)
Dementia Alcohol withdrawal
Infection
Renal impairment (electrolytes
imbalance)
Dehydration
Neurological deficit (e.g., stroke,
epilepsy)
Constipation Glycemic control
Medication (drug toxicity,
polypharmacy, side effects)
Pain
urinary retention, faecal impaction, dehydration). So, al-
though no sole predominant cause can be identified, all the
potentially relevant precipitating factors should be corrected
as possible.
6. Management of Delirium: Prevention
and Treatment
6.1. Medication Review. Once delirium is recognized in a
patient (with or without dementia), a prompt and thorough
clinical and laboratorial evaluation should be made to iden-
tify precipitating causes, which must be corrected as soon as
possible. Drug review is one of them, in order to minimize
the potential risk factors contributing to a delirium episode.
It is essential to review urgently the medications, stop any
non-essential drugs, and those with significant anticholin-
ergic effect as well as address possible drug interactions
(reviewed in Alagiakrishnan and Wiens 2004 [89]). A recent
systemic review [90] highlighted several groups of drugs that
increase the risk for delirium, such as opioids (OR 2.5, 95%
CI 1.2–52), benzodiazepines (OR-3.0, 95% CI 1.3–6.8) dihy-
dropyrdines (OR= 2.4, 95% CI 1.0–5.8), and antihistamines
(OR= 1.8, 95% CI 0.7–4.5), but not neuroleptics (OR-0.9,
95% CI 0.6–1.3) or digoxin (OR= 0.5, 95% CI 0.3–0.9). The
findings from this review recommend considering reducing
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and/or stopping benzodiazepines in subjects who are already
on them and avoid further new prescriptions of this group
of drugs, whereas the opioids should be prescribed with
caution, in people with unregulated pain.
6.2. Nonpharmacological Interventions. Multicomponent in-
terventions targeting specific risk factors for delirium have
been developed through training and educational pro-
grammes of health care staff, nonpharmacological interven-
tion protocols and improvement of the environment of the
patient [91]. Globally, these interventions, dependent on the
provision of high-quality nursing care, are effective in re-
ducing the incidence, severity, and duration of delirium.
Multicomponent interventions have been shown to be
cost-effective in preventing delirium when applied to pa-
tients at risk of delirium in a hospital setting. Important
risk factors do address and include cognitive impairment/
disorientation, dehydration/constipation, hypoxia, infection,
immobility, pain, medication, nutrition, sensory impair-
ment, and sleep [25].
These nonpharmacological interventions should be also
offered to every patient with delirium and include promoting
day activity, maintaining quite, well-lit environment, staff
continuity, avoiding room and bed changes, providing hear-
ing and visual aids, encouraging personal items, limiting
visits especially for hyperactive delirium patients, remove
noxious stimuli (e.g., catheters, pumps, etc.), limiting med-
ical monitoring and testing (e.g., measuring blood pressure,
temperature, blood works) [25]. A recent study on elderly
with dementia also found improvement of severity and dura-
tion of delirium in those elderly randomized to cognitively
stimulating activities [92].
6.3. Pharmacological Measures. Preventive pharmacological
studies have been published with different classes of med-
ication (typical antipsychotics, atypical antipsychotics, ben-
zodiazepines, cholinesterase inhibitors). Two placebo-con-
trolled trials reported a reduced incidence of delirium fol-
lowing administration of risperidone [93] and olanzapine
[94] perioperatively in cardiac and orthopaedic surgery.
Despite this promising results, the current available evidence
is insufficient to recommend a pharmacological strategy for
delirium prevention.
The use of medication is not a first-line strategy in
the treatment of a patient with delirium [25]. In some
distressed patients with hyperactive symptoms, such as ag-
itation or hallucinations, haloperidol or olanzapine can be
used cautiously (lowest effective dose for less than 1 week)
[25]. Risperidone (0.5–1 mg) and quetiapine (25–50 mg)
are reasonable alternatives [95]. Benzodiazepines are the
mainstay pharmacological treatment for delirium associated
with alcohol withdrawal (delirium tremens) but not for other
causes.
Although a number of case report studies have found
benefits of use of cholinesterase inhibitors (donepezil and
rivastigmine) in the treatment [96–99] and prevention
[98, 100] of delirium, randomized control trials have
failed to provide evidence for the effectiveness of either
donepezil [101] or rivastigmine [102, 103] in the treatment
or prevention [104] of delirium. Furthermore, the most
recent randomized control study in critically ill patients
had to be halted, due to the higher mortality rate in the
rivastigmine group compared to the control subjects (P =
.07). Furthermore, rivastigmine was associated with a more
severe type of delirium, that is, a longer stay in intensive care
unit. [103] The reported differences between the outcomes
in case reports and the open labelled trial [105] and
those in the randomized control trials may be attribuTable
to the severity of medical illness, heterogeneous clinical
samples and extent of polypharmacy. Similarly, further work
would be required to identify whether the effectiveness
of cholinesterase inhibitors may be confined to a distinct
subgroup of people with delirium, for example, elderly with
cognitive impairment.
7. Conclusions
As reviewed above, delirium is a neuropsychiatric syndrome
commonly observed in hospital setting being associated with
a wide range of adverse outcomes. The nursing care the delir-
ium patients receive, as well as the nursing role within the
multidisciplinary delivery of care is of upmost importance.
The NICE guidelines for delirium (2010) clearly identify
the important role of nursing staff not only in providing
patient-centred care (taking into account patients’ needs
and preferences, facilitating good communication), but also
in undertaking adequate interventions to prevent delirium
(management of environment, maintaining a familiar team
of healthcare professionals), and delivering of nonpharma-
cological interventions (ensuring effective communication
and reorientation, providing reassurance, engaging family,
friends and carers, so that stress and violence be avoided or
reduced/minimised). Although the current NICE guidelines
for delirium do not mention the involvement of liaison team
members, the multidisciplinary involvement should include
the expertise of Liaison Old Age Psychiatry teams [106],
that will enhance the delivery of effective nursing care, and
facilitate educational approaches [107] for dealing with the
acutely medically confused elderly.
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